{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:50:06Z","timestamp":1790776206180,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10048-019-00596-z","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T09:03:46Z","timestamp":1572080626000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1012-9783","authenticated-orcid":false,"given":"Andoni","family":"Echaniz-Laguna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Cuisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Guyant-Marechal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Aubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naziha","family":"Baaloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Verloes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouider","family":"Beladgham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Francou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,26]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mus.24321","volume":"50","author":"BL Johnson-Kerner","year":"2014","unstructured":"Johnson-Kerner BL, Roth L, Greene JP, Wichterle H, Sproule DM (2014) Giant axonal neuropathy: an updated perspective on its pathology and pathogenesis. Muscle Nerve 50:467\u2013476","journal-title":"Muscle Nerve"},{"key":"596_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/81701","volume":"26","author":"P Bomont","year":"2000","unstructured":"Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, Demir E, Topaloglu H, Korinthenberg R, T\u00fcys\u00fcz B, Landrieu P, Hentati F, Koenig M (2000) The gene encoding gigaxonin, a new member of the cytoskeletal BTB\/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 26:370\u2013374","journal-title":"Nat Genet"},{"key":"596_CR3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0960-8966(02)00029-9","volume":"12","author":"M Tazir","year":"2002","unstructured":"Tazir M, Vallat JM, Bomont P, Zemmouri R, Sindou P, Assami S, Nouioua S, Hammadouche T, Grid D, Koenig M (2002) Genetic heterogeneity in giant axonal neuropathy: an Algerian family not linked to chromosome 16q24.1. Neuromuscul Disord 12:849\u2013852","journal-title":"Neuromuscul Disord"},{"key":"596_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/humu.9122","volume":"21","author":"P Bomont","year":"2003","unstructured":"Bomont P, Ioos C, Yalcinkaya C et al (2003) Identification of seven novel mutations in the GAN gene. Hum Mutat 21:446","journal-title":"Hum Mutat"},{"key":"596_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1212\/01.WNL.0000101676.41505.A7","volume":"62","author":"C Bruno","year":"2004","unstructured":"Bruno C, Bertini E, Federico A et al (2004) Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology 62:13\u201316","journal-title":"Neurology"},{"key":"596_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jnnp.2003.035162","volume":"76","author":"E Demir","year":"2005","unstructured":"Demir E, Bomont P, Erdem S et al (2005) Giant axonal neuropathy: clinical and genetic study in six cases. J Neurol Neurosurg Psychiatry 76:825\u2013832","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"596_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/jnnp.2007.118968","volume":"78","author":"H Houlden","year":"2007","unstructured":"Houlden H, Groves M, Miedzybrodzka Z et al (2007) New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. J Neurol Neurosurg Psychiatry 78:1267\u20131270","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"596_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.nmd.2009.01.011","volume":"19","author":"M Tazir","year":"2009","unstructured":"Tazir M, Nouioua S, Magy L et al (2009) Phenotypic variability in giant axonal neuropathy. Neuromuscul Disord 19:270\u2013274","journal-title":"Neuromuscul Disord"},{"key":"596_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nmd.2013.06.007","volume":"24","author":"LA Roth","year":"2014","unstructured":"Roth LA, Johnson-Kerner BL, Marra JD, LaMarca NH, Sproule DM (2014) The absence of curly hair is associated with a milder phenotype in giant axonal neuropathy. Neuromuscul Disord 24:48\u201355","journal-title":"Neuromuscul Disord"},{"key":"596_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.braindev.2015.09.001","volume":"38","author":"R Koichihara","year":"2016","unstructured":"Koichihara R, Saito T, Ishiyama A et al (2016) A mild case of giant axonal neuropathy without central nervous system manifestation. Brain Dev 38:350\u2013353","journal-title":"Brain Dev"},{"key":"596_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12881-016-0343-x","volume":"17","author":"S Aharoni","year":"2016","unstructured":"Aharoni S, Barwick KE, Straussberg R, Harlalka et al (2016) Novel homozygous missense mutation in GAN associated with Charcot-Marie-Tooth disease type 2 in a large consanguineous family from Israel. BMC Med Genet 17:82","journal-title":"BMC Med Genet"},{"key":"596_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12519-018-0140-z","volume":"14","author":"MI Normendez-Mart\u00ednez","year":"2018","unstructured":"Normendez-Mart\u00ednez MI, Monterde-Cruz L, Mart\u00ednez R, Marquez-Harper M, Esquitin-Gardu\u00f1o N, Valdes-Flores M, Casas-Avila L, de Leon-Suarez VP, Romero-D\u00edaz VJ, Hidalgo-Bravo A (2018) Two novel mutations in the GAN gene causing giant axonal neuropathy. World J Pediatr. 14:298\u2013304","journal-title":"World J Pediatr."},{"key":"596_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","volume":"4","author":"MG Reese","year":"1997","unstructured":"Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4:311\u2013323","journal-title":"J Comput Biol"},{"key":"596_CR14","doi-asserted-by":"publisher","first-page":"W285","DOI":"10.1093\/nar\/gkm407","volume":"35","author":"RI Dogan","year":"2007","unstructured":"Dogan RI, Getoor L, Wilbur WJ, Mount SM (2007) SplicePort: an interactive splice-site analysis tool. Nucleic Acids Res 35:W285\u2013W291","journal-title":"Nucleic Acids Res"},{"key":"596_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M et al (2009) Human splicing finder: an online bio-neurogenetics informatics tool to predict splicing signals. Nucleic Acids Res 37:e67","journal-title":"Nucleic Acids Res"},{"key":"596_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10048-009-0199-8","volume":"11","author":"H Crehalet","year":"2010","unstructured":"Crehalet H, Latour P, Bonnet V et al (2010) U1 snRNA mis-binding: a new cause of CMT1B. Neurogenetics 11:13\u201319","journal-title":"Neurogenetics"},{"key":"596_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/0883073814542946","volume":"30","author":"LA Roth","year":"2015","unstructured":"Roth LA, Marra JD, LaMarca NH, Sproule DM (2015) Measuring disease progression in giant axonal neuropathy: implications for clinical trial design. J Child Neurol 30:741\u2013748","journal-title":"J Child Neurol"},{"key":"596_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.arcped.2018.09.006","volume":"25","author":"C Hoebeke","year":"2018","unstructured":"Hoebeke C, Bonello-Palot N, Audic F et al (2018) Retrospective study of 75 children with peripheral inherited neuropathy: genotype-phenotype correlations. Arch Pediatr 25:452\u2013458","journal-title":"Arch Pediatr"},{"key":"596_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021632","volume":"8","author":"J Bacquet","year":"2018","unstructured":"Bacquet J, Stojkovic T, Boyer A et al (2018) Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation. BMJ Open 8:e021632","journal-title":"BMJ Open"},{"key":"596_CR20","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/ajmg.a.33508","volume":"152A","author":"K Buysse","year":"2010","unstructured":"Buysse K, Vergult S, Mussche S, Ceuterick-de Groote C, Speleman F, Menten B, Lissens W, van Coster R (2010) Giant axonal neuropathy caused by compound heterozygosity for a maternally inherited microdeletion and a paternal mutation within the GAN gene. Am J Med Genet A 152A:2802\u20132804","journal-title":"Am J Med Genet A"},{"key":"596_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2051-5960-2-47","volume":"2","author":"A Boizot","year":"2014","unstructured":"Boizot A, Talmat-Amar Y, Morrogh D et al (2014) The instability of the BTB-KELCH protein gigaxonin causes giant axonal neuropathy and constitutes a new penetrant and specific diagnostic test. Acta Neuropathol Commun 2:47","journal-title":"Acta Neuropathol Commun"},{"key":"596_CR22","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/hmg\/ddu556","volume":"24","author":"BL Johnson-Kerner","year":"2015","unstructured":"Johnson-Kerner BL, Ahmad FS, Diaz AG, Greene JP, Gray SJ, Samulski RJ, Chung WK, van Coster R, Maertens P, Noggle SA, Henderson CE, Wichterle H (2015) Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin. Hum Mol Genet 24:1420\u20131431","journal-title":"Hum Mol Genet"},{"key":"596_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140157","volume":"10","author":"BL Johnson-Kerner","year":"2015","unstructured":"Johnson-Kerner BL, Garcia Diaz A, Ekins S, Wichterle H (2015) Kelch Domain of gigaxonin interacts with intermediate filament proteins affected in giant axonal neuropathy. PLoS One 10:e0140157","journal-title":"PLoS One"},{"key":"596_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13023-018-0957-5","volume":"14","author":"D Armao","year":"2019","unstructured":"Armao D, Bouldin TW, Bailey RM et al (2019) Advancing the pathologic phenotype of giant axonal neuropathy: early involvement of the ocular lens. Orphanet J Rare Dis 14:27","journal-title":"Orphanet J Rare Dis"},{"key":"596_CR25","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1172\/JCI66387","volume":"123","author":"S Mahammad","year":"2013","unstructured":"Mahammad S, Murthy SN, Didonna A, Grin B, Israeli E, Perrot R, Bomont P, Julien JP, Kuczmarski E, Opal P, Goldman RD (2013) Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. J Clin Invest 123:1964\u20131975","journal-title":"J Clin Invest"},{"key":"596_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.omtm.2018.02.005","volume":"9","author":"Rachel M. Bailey","year":"2018","unstructured":"Bailey RM, Armao D, Nagabhushan Kalburgi S, Gray SJ (2018) Development of intrathecal AAV9 gene therapy for giant axonal neuropathy. Mol Ther Methods Clin Dev:160\u2013171","journal-title":"Molecular Therapy - Methods & Clinical Development"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-019-00596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10048-019-00596-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-019-00596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T23:17:27Z","timestamp":1603581447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10048-019-00596-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,26]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s10048-019-00596-z","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,26]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was accepted and achieved under the ethical guidelines issued by our institutions for clinical studies. This study was in compliance with the Helsinki Declaration. All patients gave informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}